JP2015500883A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015500883A5 JP2015500883A5 JP2014548851A JP2014548851A JP2015500883A5 JP 2015500883 A5 JP2015500883 A5 JP 2015500883A5 JP 2014548851 A JP2014548851 A JP 2014548851A JP 2014548851 A JP2014548851 A JP 2014548851A JP 2015500883 A5 JP2015500883 A5 JP 2015500883A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- group
- alkoxy
- compound according
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161578456P | 2011-12-21 | 2011-12-21 | |
| US61/578,456 | 2011-12-21 | ||
| PCT/US2012/070710 WO2013096501A1 (en) | 2011-12-21 | 2012-12-19 | Compounds acting at multiple prostaglandin receptors giving a general anti-inflammatory response |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015500883A JP2015500883A (ja) | 2015-01-08 |
| JP2015500883A5 true JP2015500883A5 (https=) | 2016-02-18 |
| JP6132851B2 JP6132851B2 (ja) | 2017-05-24 |
Family
ID=47436296
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014548851A Expired - Fee Related JP6132851B2 (ja) | 2011-12-21 | 2012-12-19 | 一般的な抗炎症反応を与える複数のプロスタグランジン受容体において作用する化合物 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US8969589B2 (https=) |
| EP (1) | EP2794574B1 (https=) |
| JP (1) | JP6132851B2 (https=) |
| AU (1) | AU2012358983B2 (https=) |
| CA (1) | CA2860392C (https=) |
| WO (1) | WO2013096501A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106146400A (zh) * | 2015-03-20 | 2016-11-23 | 四川大学 | 苄基-1h-吡唑、苄基-1h-吡咯衍生物及其制备方法和用途 |
| US9827225B2 (en) | 2016-01-25 | 2017-11-28 | Jenivision Inc. | Use of prostacyclin antagonists for treating ocular surface nociception |
| WO2017153234A1 (de) * | 2016-03-09 | 2017-09-14 | Bayer Pharma Aktiengesellschaft | Substituierte n-cyclo-2-arylchinolin-4-carboxamide und ihre verwendung |
| WO2017153231A1 (de) * | 2016-03-09 | 2017-09-14 | Bayer Pharma Aktiengesellschaft | Substituierte n-cyclo-2-arylisochinolinon-4-carboxamide und ihre verwendung |
| US20230390303A1 (en) | 2020-11-13 | 2023-12-07 | Ono Pharmaceutical Co., Ltd. | Cancer treatment by combination of ep4 antagonist and immune checkpoint inhibitor |
| CN118184646A (zh) * | 2024-05-14 | 2024-06-14 | 苏州弘道新材料有限公司 | 用于光伏胶膜的吡唑啉衍生物光转换材料及其制备方法和应用 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4166452A (en) | 1976-05-03 | 1979-09-04 | Generales Constantine D J Jr | Apparatus for testing human responses to stimuli |
| US4256108A (en) | 1977-04-07 | 1981-03-17 | Alza Corporation | Microporous-semipermeable laminated osmotic system |
| US4265874A (en) | 1980-04-25 | 1981-05-05 | Alza Corporation | Method of delivering drug with aid of effervescent activity generated in environment of use |
| US7273883B2 (en) | 2000-09-14 | 2007-09-25 | Allergan, Inc. | Prostaglandin EP4 antagonist |
| US7217725B2 (en) | 2000-09-14 | 2007-05-15 | Allergan, Inc. | Prostaglandin D2 antagonist |
| US6511999B2 (en) | 2000-09-14 | 2003-01-28 | Allergan, Inc. | Interheteroaryl 7-oxabicyclic [2.2.1]heptane oxazoles as prostaglandin F2α antagonists |
| ES2298832T3 (es) * | 2003-10-24 | 2008-05-16 | Glaxo Group Limited | Compuestos heterociclicos. |
| GB0508472D0 (en) | 2005-04-26 | 2005-06-01 | Glaxo Group Ltd | Compounds |
| US8492424B2 (en) * | 2010-07-01 | 2013-07-23 | Allergan, Inc. | Compounds act at multiple prostaglandin receptors giving a general anti-inflammatory response |
-
2012
- 2012-12-19 AU AU2012358983A patent/AU2012358983B2/en not_active Ceased
- 2012-12-19 JP JP2014548851A patent/JP6132851B2/ja not_active Expired - Fee Related
- 2012-12-19 EP EP12806863.2A patent/EP2794574B1/en not_active Not-in-force
- 2012-12-19 WO PCT/US2012/070710 patent/WO2013096501A1/en not_active Ceased
- 2012-12-19 CA CA2860392A patent/CA2860392C/en active Active
- 2012-12-19 US US13/720,230 patent/US8969589B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015500883A5 (https=) | ||
| JP2013535424A5 (https=) | ||
| JP2018535967A5 (https=) | ||
| JP5539734B2 (ja) | チオピリミジンベースの化合物およびその使用 | |
| EA201100423A1 (ru) | Новые бензамиды, их получение и их применение в качестве лекарственных средств | |
| ES2637009T3 (es) | Nuevos derivados de 1-bencil-3-hidroximetilindazol y su utilización en el tratamiento de enfermedades basadas en la expresión de CX3CR1 y p40 | |
| CN103443098B (zh) | 作为溶血磷脂酸受体的拮抗剂的化合物、组合物及其应用 | |
| JP2017530959A5 (https=) | ||
| EA201270561A1 (ru) | Антагонисты рецептора cgrp | |
| JP2019535761A5 (https=) | ||
| JP2012255002A5 (https=) | ||
| RU2011147374A (ru) | Диамидные соединения, обладающие активностью антагониста мускаринового рецептора и активностью агониста в2 адренергического рецептора | |
| JP2005194283A5 (https=) | ||
| JP2003525295A5 (https=) | ||
| JP2017510624A5 (https=) | ||
| CN1048239C (zh) | 萘衍生物 | |
| CA2656057A1 (en) | Crystalline forms of 4-[2-(4-methylphenylsulfanyl)-phenyl]piperidine with combined serotonin and norepinephrine reuptake inhibition for the treatment of neuropathic pain | |
| JP2008505171A5 (https=) | ||
| JP2009539890A5 (https=) | ||
| JP2025165966A5 (https=) | ||
| CN1555356A (zh) | 作为nhe-3抑制剂的双酚衍生物 | |
| RU2019121673A (ru) | Активаторы nrf2 | |
| JP2011503072A5 (https=) | ||
| JP2015503562A5 (https=) | ||
| JP2010540649A5 (https=) |